Harnessing Reconstructed Macrophage Modulation of Infiltration-Excluded Immune Microenvironments To Delineate Glioma Infiltrative Region
Source abstract
Abstract
High invasiveness of glioma produces residual glioma cells in the brain parenchyma after surgery and ultimately causes recurrence. Precise delineation of glioma infiltrative region is critical for an accurate complete resection, which is challenging. The glioma-infiltrating area constitutes infiltration-excluded immune microenvironments (I-E TIMEs), which recruits endogenous or adoptive macrophages to the invasive edge of glioma. Thus, combined with immune cell tracing technology, we provided a novel strategy for the preoperative precise definition of the glioma infiltration boundary, even satellite-like infiltration stoves. Herein, the biomimetic probe was constructed by internalizing fluorophore labeled PEGylated KMnF 3 nanoparticles into bone-marrow-derived macrophages using magnetic resonance imaging (MRI)/fluorescence imaging (FI). The biomimetic probe was able to cross the blood–brain barrier and home to the orthotopic glioma infiltrates including satellite stove under MRI and FI tracing, which was validated using hematoxylin and eosin staining, indicating its excellent performance in distinguishing the margins between the glioma cell and normal tissues. This study guides the precise definition of glioma infiltration boundaries at the cellular level, including the observation of any residual glioma cells after surgery. Thus, it has the potential to guide surgery to maximize resection and predict recurrence in the clinic.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immune cells in cancer · Glioma Diagnosis and Treatment · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
College of Chemistry and Chemical Engineering, Qingdao University, Qingdao 266071, China
Department of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Qingdao Traditional Chinese Medicine
References (47)
Show source-provided references
1. 10.1038/s41392-021-00724-y10.1038/s41392-021-00724-y ↗
2. 10.1038/s41598-018-34521-510.1038/s41598-018-34521-5 ↗
3. 10.1038/nrn376510.1038/nrn3765 ↗
4. 10.1038/nrd.2015.2110.1038/nrd.2015.21 ↗
5. 10.1016/j.bbcan.2010.04.00110.1016/j.bbcan.2010.04.001 ↗
6. 10.1158/0008-5472.CAN-09-115710.1158/0008-5472.CAN-09-1157 ↗
7. 10.7150/thno.2478410.7150/thno.24784 ↗
8. 10.1212/WNL.59.6.94710.1212/WNL.59.6.947 ↗
9. 10.1038/s41598-017-03633-910.1038/s41598-017-03633-9 ↗
10. 10.1002/adma.20160391710.1002/adma.201603917 ↗
11. 10.1039/C9TB02391G10.1039/C9TB02391G ↗
12. 10.1021/nn406197c10.1021/nn406197c ↗
13. 10.1002/smll.20070078410.1002/smll.200700784 ↗
14. 10.1021/nl050256910.1021/nl0502569 ↗
15. 10.7150/thno.2522010.7150/thno.25220 ↗
16. 10.1093/ndt/gfk06210.1093/ndt/gfk062 ↗
17. 10.1038/s41591-018-0014-x10.1038/s41591-018-0014-x ↗
18. 10.3389/fchem.2020.0080410.3389/fchem.2020.00804 ↗
19. 10.1016/j.ccr.2011.08.02510.1016/j.ccr.2011.08.025 ↗
20. 10.1074/jbc.M113.49902010.1074/jbc.M113.499020 ↗
21. 10.1021/acsami.1c1240610.1021/acsami.1c12406 ↗
22. 10.1038/s41587-019-0064-810.1038/s41587-019-0064-8 ↗
23. 10.1021/acsnano.1c0868910.1021/acsnano.1c08689 ↗
24. 10.1016/j.biomaterials.2019.04.02610.1016/j.biomaterials.2019.04.026 ↗
25. 10.1016/j.colsurfb.2022.11249310.1016/j.colsurfb.2022.112493 ↗
26. 10.1038/s41551-021-00822-w10.1038/s41551-021-00822-w ↗
27. 10.1039/c3nr00721a10.1039/c3nr00721a ↗
28. 10.1088/0957-4484/25/15/15510110.1088/0957-4484/25/15/155101 ↗
29. 10.1186/1556-276X-9-43410.1186/1556-276X-9-434 ↗
30. 10.1016/S0021-9258(18)90609-510.1016/S0021-9258(18)90609-5 ↗
31. 10.1016/j.jim.2019.11269310.1016/j.jim.2019.112693 ↗
32. 10.1006/exnr.1999.724910.1006/exnr.1999.7249 ↗
33. 10.3390/ijms2110370410.3390/ijms21103704 ↗
34. 10.18632/oncotarget.373010.18632/oncotarget.3730 ↗
35. 10.1016/j.nano.2009.10.00110.1016/j.nano.2009.10.001 ↗
36. 10.1038/s41590-022-01267-210.1038/s41590-022-01267-2 ↗
37. 10.1002/adma.20210992510.1002/adma.202109925 ↗
38. 10.1016/j.biomaterials.2011.06.02410.1016/j.biomaterials.2011.06.024 ↗
39. 10.1016/j.biomaterials.2019.11949110.1016/j.biomaterials.2019.119491 ↗
40. 10.3390/ijms22181011810.3390/ijms221810118 ↗
41. 10.1038/s41573-022-00520-510.1038/s41573-022-00520-5 ↗
42. 10.1186/s40478-021-01156-z10.1186/s40478-021-01156-z ↗
43. 10.3390/cancers1412284410.3390/cancers14122844 ↗
44. 10.1227/NEU.000000000000103510.1227/NEU.0000000000001035 ↗
45. 10.1007/s11060-013-1348-310.1007/s11060-013-1348-3 ↗
46. 10.1186/s13287-018-1076-x10.1186/s13287-018-1076-x ↗
47. 10.1089/scd.2008.025310.1089/scd.2008.0253 ↗